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Abstract India and other countries in Asia are experiencing
rapidly escalating epidemics of type 2 diabetes (T2D) and
cardiovascular disease. The dramatic rise in the prevalence of
these illnesses has been attributed to rapid changes in demo-
graphic, socioeconomic, and nutritional factors. The rapid tran-
sition in dietary patterns in India—coupled with a sedentary
lifestyle and specific socioeconomic pressures—has led to an
increase in obesity and other diet-related noncommunicable
diseases. Studies have shown that nutritional interventions
significantly enhance metabolic control and weight loss. Cur-
rent clinical practice guidelines (CPGs) are not portable to
diverse cultures, constraining the applicability of this type of
practical educational instrument. Therefore, a transcultural
Diabetes Nutrition Algorithm (tDNA) was developed and then
customized per regional variations in India. The resultant India-
specific tDNA reflects differences in epidemiologic, physio-
logic, and nutritional aspects of disease, anthropometric cutoff
points, and lifestyle interventions unique to this region of the
world. Specific features of this transculturalization process for
India include characteristics of a transitional economy with a
persistently high poverty rate in a majority of people; higher
percentage of body fat and lower muscle mass for a given body
mass index; higher rate of sedentary lifestyle; elements of the
thrifty phenotype; impact of festivals and holidays on adher-
ence with clinic appointments; and the role of a systems or
holistic approach to the problem that must involve politics,
policy, and government. This Asian Indian tDNA promises to
help guide physicians in the management of prediabetes and
T2D in India in a more structured, systematic, and effective way
compared with previous methods and currently available CPGs.
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Introduction
The transcultural Diabetes Nutrition Algorithm (tDNA) is
being developed under the direction of an international panel
of expert health care professionals. The tDNA is intended to 1)
increase awareness of the benefits of nutritional interventions
for patients with prediabetes and type 2 diabetes (T2D); 2)
encourage healthy eating practices that accommodate regional
differences in lifestyles, foods, and cultures; 3) enhance the
implementation of existing clinical practice guidelines (CPGs)
for prediabetes and T2D management; and 4) simplify nutri-
tional therapy for patients with prediabetes and T2D by facil-
itating global application and portability. The tDNA represents
a consensus of highly experienced practitioners, researchers,
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and academicians and is supported by evidence and opinion
that were rated based on scientific substantiation, according to
the standards expressed in the American Association of Clin-
ical Endocrinologists “Protocol for Standardized Production of
Clinical Practice Guidelines—2010 Update” [1]. Customiza-
tion per regional variations in dietary habits, culture, lifestyle,
body mass index (BMI), and other parameters was initiated as
a part of the first regional conference in India.
India and other countries in Asia (Note: throughout the text:
“Southeast Asian” refers to natives of India, Pakistan, and
Bangladesh; “Asian Indian” refers to people who resided in
India and migrated to East and South Africa, the United King-
dom, Singapore, Indonesia, and the United States; “East Asian”
refers to people living in China, Korea, Taiwan, etc.; and the
term “South Asian” is more generic than “Southeast Asian” or
“Asian Indian”) are experiencing rapidly escalating epidemics
of T2D and cardiovascular disease (CVD). This dramatic rise
in T2D has been attributed to rapid changes in demographic,
socioeconomic, and nutritional factors. These epidemiologic,
nutritional, financial, and social transitions are characteristic for
“transitional economies.” According to the Diabetes Atlas 5
[2], India currently has the second largest number of people
with T2D in the world; this has been confirmed by a recent
national study [3]. The Indian Council of Medical Research–
India Diabetes (ICMR–INDIAB) study [3, 4] is a community-
based survey conceived with the aim of identifying prevalence
rates of T2D in India as a whole (covering all 28 states, the
National Capital Territory of Delhi, and 2 of the union territo-
ries in the mainland of India), in a phased manner, with a total
proposed sample size of 124,000 individuals. According to the
first phase results of this study—done in four states of India
representing north, south, east, and west, and covering a pop-
ulation of 218 million people—there are currently 62.4 million
people with T2D and 77.2 million people with prediabetes [3].
Multiple logistic regression analysis showed that age, male
gender, family history of T2D, urban residence, abdominal
obesity, generalized obesity, hypertension, and income status
were significantly associated with T2D. Significant risk factors
for prediabetes were age, family history of T2D, abdominal
obesity, hypertension, and income status.
This review highlights key forces that have incited tran-
sitions in India, increased the burden of T2D in India, and
led to the transculturalization required for an Asian Indian
tDNA development. Furthermore, this review demonstrates
the importance of the Asian Indian tDNA in primary, sec-
ondary, and tertiary T2D prevention strategies.
Epidemiologic Transitions to Noncommunicable
Diseases
Demographic and associated economic and sociologic changes
induce complex shifts in health, disease states, and mortality
rates. In transition economies, especially in developing countries
such as India, infectious and communicable diseases are being
replaced by chronic degenerative or metabolic noncommuni-
cable diseases (NCDs) as the primary causes of morbidity and
mortality [5]. This epidemiologic transition in India contrib-
utes to premature deaths in adults, particularly in urban areas
[6]. There is also emerging evidence for infective agents in the
development of chronic diseases, as shown by raised concen-
trations of inflammatory markers [7]. Studies from India sup-
port the view that urbanization increases the levels of certain
cytokines and contributes in some measure to the urban–rural
differences in NCD risk [8].
On the one hand, when Asian Indian migrants adopt the
lifestyles—including the dietary patterns and broad socio-
cultural practices—of the indigenous population, they take
on the disease patterns of the native population as well.
Conversely, following migration, a genetic predisposition
to the risk of early-onset adult NCDs can be unmasked.
One specific example of the interplay between environmen-
tal and genetic factors is the increased risk of T2D and
NCDs among Asian Indian migrants to the United Kingdom
[9]. Another important feature of the developmental transi-
tion in India is the rapid urbanization and large population
shifts from rural to urban areas [6].
The impact of nutritional transitions and related metabol-
ic disorders has been regarded as diet-related noncommuni-
cable diseases by a consensus group formed for revising
previous dietary guidelines for India. The rapid nutritional
transition observed in India results in excess consumption of
calories, saturated fats, trans fatty acids, simple sugars, and
salt, with low intake of fiber, monounsaturated fatty acids,
and n-3 polyunsaturated fatty acids. This dietary pattern,
coupled with sedentary behaviors, promotes obesity, T2D,
and CVD in both urban and rural areas [10]. This phenom-
enon has recently been confirmed by the first phase results
of the ICMR–INDIAB study [3].
Fetal Origins Hypothesis in India and Its Role
in Diabetes
The susceptibility to T2D may be conferred by evolutionary
enrichment of thrifty genes, which long ago enhanced sur-
vival during periods of famine, but have now created detri-
ment with conditions of plentiful food and sedentary
lifestyles [11]. An alternative explanation that has been
recently proposed is the thrifty phenotype hypothesis (sub-
sequently generalized as fetal origins), which links the obe-
sity and T2D epidemic to an unfavorable intrauterine
environment [12, 13]. This thinking is based on certain
observations of an inverse relationship between birth weight
and risk of T2D and metabolic syndrome (MS) in elderly
populations.
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Asians, as a group, have small body size. Women from
the rural parts of India are small and are thought to be
chronically undernourished because of their low BMI. Iron
and other nutrient deficiencies are very common in this
group. Indian babies are the smallest in the world; one-
third are born with low birth weight (LBW; <2.5 kg) [14].
Thus, it is possible that maternal and fetal undernutrition
contribute to the T2D epidemic in Asian countries [15]. In
Indians, T2D is diagnosed at least a decade earlier and
individuals are considerably thinner than their UK counter-
parts [15]. Indians have thinner limbs, which is suggestive
of smaller muscle mass. However, despite their thinness,
they are centrally obese, with higher waist-hip ratio
(WHR) and higher subscapular-triceps skinfold ratio than
their UK counterparts [15]. Many studies show that Indians
have more body fat for any given BMI compared with
Caucasians and black Africans [16, 17]. Indians also have
higher levels of central obesity (measured as waist circum-
ference [WC], WHR, visceral fat, and posterior subcutane-
ous abdominal fat). This is reflected in higher plasma
nonesterified fatty acid and triglyceride concentrations,
hyperinsulinemia with fasting as well as post-glucose chal-
lenge states, and higher insulin resistance [18]. Thus, Indi-
ans have an unusual thin-fat body composition associated
with the insulin resistance syndrome.
The Pune Maternal Nutrition Study [19, 20] has given
insight into fetal development in Indian populations. This
prospective, population-based, observational research
assessed rural Indian women and their offspring. Mothers
were short and thin (mean pre-pregnant height and BMI:
152 cm and 18.1 kg/m2, respectively); mean full-term birth
weight was only 2.7 kg. Detailed anthropometry of the
newborns showed that their body composition differed from
white Caucasian babies born in the United Kingdom. The
Indian babies were lighter by almost 2 standard deviations
(SDs), and lean tissues such as muscle (mid-upper arm
circumference) and abdominal viscera (abdominal circum-
ference) showed a similar deficit. However, truncal fat (sub-
scapular skinfolds) was relatively spared (−0.5 SD). Thus,
although extremely small and thin, the babies had relatively
increased adiposity. A similar pattern is seen in urban Indian
adults. It has been suggested that increasing maternal parity
predicts increasing adiposity in the newborn infant. This
may result from maternal nutritional, cardiovascular, or
immunologic factors [19, 20].
Nutrition Transition and Increased Risk of T2D
Epidemiologic, nutritional, and economic transitions have
also revealed certain trends and patterns in the nutritional
transition in India. A hectic lifestyle and the easy availability
of convenience foods have led to irregular meals and frequent
snacking on energy-dense fast foods, including ready-to-use
gravies and soups, packaged salty snacks, ready-made cook-
ies, and commercial fast foods, rather than traditional home-
cooked food. Furthermore, consumption of animal foods,
sugar (especially sweetened, carbonated beverages), and tra-
ditional Indian energy-dense foods has also increased. The
diets of all income groups have moved away from whole-
grain cereals to other food groups, with greater shifts noted
among the urban populations and the higher-income groups
[10].
India progressed toward caloric adequacy in the 1970s
and early 1980s, as documented by the National Nutrition
Monitoring Bureau [21] and other surveys. The surveys
showed a gradual improvement in caloric intake per capita,
typified by an increase in consumption of cereal grains,
while the intake of most other food items—such as milk,
oil, sugar, etc.—remained largely unchanged. However,
many of these surveys revealed disparities in the intakes of
most foods between rural and urban populations and be-
tween different socioeconomic groups. Comparison of food
consumption patterns shows a gradual reduction in cereal
grain consumption between 1975 and 1995 that has not
affected the average energy intake. This is largely the result
of a progressive increase in the intake of protein and, likely,
fats. The latter is due to a significant increase in the con-
sumption of milk and other dairy products, as well as an
increase in the intake of animal products (designated flesh
foods), fats, and oils. The production of pulses and legumes
is also a concern; consequently, their cost and consumption
have fallen dramatically. This is somewhat worrisome be-
cause pulses and legumes were once a very important source
of vegetable proteins in the traditional Indian diet. Trends in
the changes in consumption of urban populations are not
readily available, although the surveys conducted between
the late 1970s and the 1990s show wide differences between
the socioeconomic strata in an urban environment. One
would have expected these disparities to have widened
further over the years, although this is not evident from the
data [21].
While carbohydrates remain the major source of energy in
Indian diets, the percentage of total energy intake derived
from carbohydrates has declined (1975–1979, 80.3%; 2001,
75.5%); however, the quality of carbohydrates has changed
from the traditional high-fiber carbohydrates to the low-fiber
carbohydrates such as polished white rice, which has a higher
glycemic index. There is also an increase in the percentage of
energy coming from dietary fats (1975–1979, 8.9%; 2001,
13.9%). However, the proportion of dietary energy coming
from fat still remains less than 15%, which is lower than the
recommended dietary allowance of 15% to 30% [22]. Con-
sumption of oils, fats, and animal products has increased in
almost all the states [21]. Energy intake is lower in urban
areas, in spite of higher intake of fats and oils, because of
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lower cereal consumption compared with rural areas [23].
Reasons for these dichotomous observations of decreased
energy intake with rising prevalence of obesity could be
under-reporting of dietary consumption data [23], higher en-
ergy intake compared with energy expenditure [24], and in-
creasingly sedentary lifestyles [21–24].
Regional Disparities in India
India is a diverse country covering 28 states, the National
Capital Region of Delhi, and several union territories in the
mainland of India. Regional disparities in prediabetes and
T2D are common, attributable to the vast variation in culture
and dietary habits across regions. In an attempt to under-
stand these variations and disparities, there has been an
explosion in T2D epidemiology studies in India over the
past 20 years [25]. In the large cities of north and south India
(Chennai [26–28], Trivandrum [29, 30], Mumbai [31],
Delhi [32, 33], Jaipur [34], and Gauhati [35]), in large
metropolises [36], and in industrial populations [37], T2D
prevalence among adults (>20 years of age) has ranged from
8% to 15%. Within urban populations, a large heterogeneity
of T2D prevalence is noted, depending on the socioeconomic
stratum studied and sampling response rates.
There are few epidemiological studies in semi-urban India
[38, 39], and many in rural populations [40, 41]. In earlier years,
there was a very low prevalence of T2D in rural populations.
However, recent studies from Maharashtra [42] and Andhra
Pradesh [43] report very high prevalence rates similar to those
in urban Indian populations. Interestingly, a significant correla-
tion of BMI with T2D has been observed in these studies. It has
been hypothesized that although there is a significant increase in
T2D as populations move from rural to semi-urban to urban and
cosmopolitan habitats, a reversemigration of culturemay already
be taking place in Indian rural populations. Earlier rural–urban
disparities in T2D could be due to a low prevalence of over-
weight and obesity in rural, compared to urban, subjects [44].
The recent ICMR–INDIAB study [3] has featured the re-
gional disparities more prominently, with the first phase results
stating that in 2011, Maharashtra will have 6 million individ-
uals with T2D and 9.2 million with prediabetes; Tamilnadu
will have 4.8 million people with T2D and 3.9 million with
prediabetes; Jharkhandwill have 0.96million people with T2D
and 1.5 million with prediabetes; and Chandigarh will have
0.12 million people with T2D and 0.13 million with prediabe-
tes. With greater urbanization, growth of the middle class, and
aging of the population, tremendous increases in the numbers
of people with T2D in India are projected in the future [3].
In south India, rice is the staple food, and highly polishedwhite
rice has been linked to T2D [45, 46] and MS [47]. The ICMR-
INDIAB studymay help to throwmore light on the role of dietary
factors in the differences in T2D and prediabetes prevalence rates.
Studies confirm that risk factors tend to develop early in the
life cycle in Indian subjects; consequently, T2D occurs at least
10 to 15 years earlier than it does in people of non-Indian
origin [48]. The generalized and central obesity levels at which
T2D occurs are also lower in Indian subjects compared with
Caucasian populations [49]. For Southeast Asians and Asian
Indians, a waist size of greater than 90 cm in men and greater
than 80 cm in women is now accepted as a major risk factor for
T2D and other CVD risk factors of MS [50]. The influence of
societal affluence levels on T2D prevalence in India suggests
that a global solution with the greatest impact on reducing the
T2D epidemic lies with policy makers and governments [51].
There is a need to change the economic/environmental struc-
ture and culture in urban areas of India so that physical activity
and healthy dietary choices are available [52].
Trends and Transition in Obesity
Obesity has increased rapidly in many populations in recent
years [53–55] due to an interaction between genetic and
environmental factors. These include metabolic characteristics
[51, 52, 56], physical inactivity [57–59], habitual energy
intake in relation to expenditure, and macronutrient composi-
tion of the diet [60–64]. The increases in obesity prevalence
have been accompanied by concomitant increases in T2D
prevalence [56]; so much so that an etiological connection
between the two seems obvious. Data from the Nurses’Health
study suggest that the lowest risk of T2D occurs in individuals
who have a BMI less than 21 kg/m2, with increasing preva-
lence seen as obesity levels increase [56]. Those with higher
BMIs have much higher incidence rates of T2D at earlier ages
than those with lower BMIs, among whom the incidence rises
in the older age groups. Several studies indicate that WC or
WHR may be a better indicator of the risk of developing
diabetes than BMI [65–67]. Such data suggest that the distri-
bution of body fat is an important determinant of risk, as these
measures reflect abdominal or visceral obesity.
A recent review has shown higher risks for Asians com-
pared with Caucasians for the development of obesity and
obesity-related NCDs (OR-NCDs), including insulin resis-
tance, MS, T2D, and CVD [68]. Differences in determinants
and associated factors for OR-NCDs between Asian Indians
and Caucasians include body phenotype (high body fat; high
truncal, subcutaneous and intra-abdominal fat; and low mus-
cle mass), biochemical parameters (hyperinsulinemia, hyper-
glycemia, dyslipidemia, hyperleptinemia, low levels of
adiponectin, and high levels of C-reactive protein), procoagu-
lant state, and endothelial dysfunction [69, 70]. Epidemiologic
research has demonstrated an association between low muscle
mass and increased insulin resistance [71], whichmay relate to
phenotype, aging with muscle wasting, low dietary protein
intake, or insufficient resistance training. Higher prevalence,
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earlier onset, and increased occurrence of T2D and CVD are
often seen at lower levels of BMI and WC in Asian Indians
than in Caucasians. Given the importance of central adiposity
as a determinant of T2D risk, it is necessary to consider whether
the usually quoted normal range for BMI (18.5–24.9 kg/m2) is
appropriate for all populations. Lower cutoffs for obesity and
abdominal obesity have been advocated for Asian Indians
(BMI: overweight >23 to 24.9 kg/m2 and obesity ≥25 kg/m2;
WC: men ≥90 cm and women ≥80 cm, respectively). A min-
imal rise in the BMI or WC would act adversely in a subject
with a genetic susceptibility to T2D. Studies in India have
shown that central obesity was more strongly associated with
glucose intolerance than generalized obesity was [68].
In urban India, data show a prevalence of obesity of 10%
and 15.1% (2003) [72]; 20.8% and 32.3% (2004) [73]; and
43.2% and 47.4% (2007) in men and women, respectively
[74]. Interestingly, a high prevalence has been reported in
economically disadvantaged adults residing in urban slums
(14%) [32], specifically in postmenopausal women (28%)
[75]. An increased prevalence of obesity has also been
reported in rural areas from 8% reported in 1997 [76] to
32.4% in men and 41.4% in women in 2007 [77]. Of
particular concern, childhood obesity is also increasing from
16% in 2002 to about 24% in 2006 in North India [78], and
from 4.9% in 2003 to 6.6% in 2005 in South India [79].
Trends and Transition in Physical Inactivity
Numerous studies have indicated the importance of physical
inactivity in the development T2D [80, 81]. In the Nurses’
Health Study [81], women who reported exercising vigorously
had an age-adjusted incidence rate of self-reported, clinically
diagnosed T2D that was two thirds as high as that of women
who exercised less frequently. The deleterious effect of low
levels of physical activity is seen particularly among those
subjects who have other risk factors, such as high BMI, hyper-
tension, or parental T2D. Similarly, among male physicians,
the incidence of self-reported T2D was negatively related to
the frequency of vigorous exercise, and the strength of this
relationship was greater in those with higher BMI [80]. For
equivalent degrees of obesity, more physically active subjects
have a lower incidence of the disease [82].
Several studies have shown that Asian Indians are more
sedentary than Caucasians [83]. For example, findings from
the Newcastle Heart Project (comprising Asian Indians [n0
105] and Europeans [n0416]) showed that Asian Indians are
less physically active than Europeans. Similarly, another UK
study showed that lower physical activity in Asian Indians,
Pakistanis, or Bangladeshis, compared with their European
counterparts, was inversely correlated with BMI,WC, systolic
blood pressure, plasma glucose, and plasma insulin levels
[84]. The prevalence of T2D and impaired glucose tolerance
has been shown to be significantly lower in higher quartiles of
physical activity in South Indians (ie, 17.0%, 9.7%, and 5.6%
for sedentary, moderately heavy, and heavy physical activity,
respectively) [85]. It is believed that a sedentary lifestyle is an
important factor contributing to the development of T2D and
CVD in Asian Indians [86, 87]. The Consensus Development
Group for formulating the Consensus Physician Activity
Guidelines for Asian Indians considered the available physical
activity guidelines from international and Indian studies and
formulated the following India-specific guidelines.
A total of 60 min of physical activity per day is recom-
mended for healthy Asian Indians, in view of the high predis-
position to develop T2D and CVD. This should include at
least 30 min of moderate-intensity aerobic activity, 15 min of
work-related activity, and 15 min of muscle-strengthening
exercises. For children, moderate-intensity physical activity
for 60 min daily should be in the form of sports and physical
activity. This consensus statement also includes physical ac-
tivity guidelines for pregnant women, the elderly, and those
suffering from obesity, T2D, CVD, and other components of
MS. Proper application of guidelines is likely to have a sig-
nificant impact on the prevalence and management of these
cardiometabolic factors in Asian Indians [88].
Studies have looked at a community-based participatory
research approach to translate the original Diabetes Prevention
Program in the United States into one that is age-specific and
culture-specific for other regions of the world. These studies
have evaluated cultural strategies for healthy behaviors, includ-
ing culture-specific physical activities, knowledge and access
to healthy foods, physical activity for youth and their parents,
interactive hands-on learning activities for healthy lifestyles,
and group formats for adopting healthy behaviors [89].
Barriers to Clinical Management
Sociocultural and religious factors influence health beliefs,
diet, and lifestyle management in Asian Indians [90–92].
Cultural factors (eg, festivals and holidays) contribute to a
greater frequency of missed clinic appointments by Asian
Indians compared with Caucasians. Furthermore, poor ad-
herence with T2D therapy (insulin or oral agents) is com-
mon among Asian Indians during holidays, and glycemic
control is unsatisfactory due to religious fasting [93–95].
Asian Indian patients with T2D also tend to have a more
negative attitude and tend to believe they were made to wait
longer in clinics than UK Caucasians do [96]. Response to
drugs has been suspected to be different in Asian Indians
compared with Caucasians, but this phenomenon has not been
adequately investigated. Prevalence of associated conditions
such as dyslipidemia, hypertension, and CVD is also affected
by differences in body fat composition, dietary changes, ab-
dominal obesity, and BMI [69]. A recent study showed that
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self-efficacy is an important factor in determining outcomes
[97]. In contrast, an advantageous sociocultural factor seen in
Asian Indians is the extended family structure, often helping
patients to cope better with insulin therapy and morbidities.
Asian Indian Holistic Approach Toward Management
of Prediabetes and T2D
The enormous social and personal cost of T2D makes a com-
pelling case for prevention. In view of the evidence and the
devastating health impact of cardiometabolic disease, it seems
prudent that primary prevention should be a major priority. The
greatest hope lies in implementing lifestyle intervention pro-
grams on a large scale, targeting multiple nodes in a complex
cultural network or system, buttressed by a favorable political
and regulatory strategy, and initially focused on high-risk per-
sons. Meta-analysis studies [98] looking at T2D education and a
variety of weight loss methods have shown that nutrition inter-
ventions have the largest statistically significant effect on meta-
bolic control and weight loss. In addition, these meta-analyses
have shown that T2D education, in general, is effective in
improving knowledge, skills, psychosocial adjustment, andmet-
abolic control. Overall, the evidence involving medical nutrition
therapy in T2D management supports nutritional intervention.
Conclusions
Many developing countries, including India, now report the
onset of T2D at increasingly younger ages. This trend toward
younger age of onset implies a huge additional burden to the
affected individuals and to society, and necessitates a lifetime
approach to prevention and treatment. To achieve maximal
benefit from lifestyle interventions, changes in governmental
policies and legislation will be needed, in addition to individ-
ual and community-based programs. Thus, evidence-based
advice to governments and public health authorities must
emphasize the role of weight reduction in the overweight
and obese, nutritional interventions, and modified focused
lifestyle interventions. This approach can also be expected to
have a positive effect on the prevention of other major NCDs,
such as CVD and hypertension. The tDNA focuses on inter-
ventions in prediabetes and T2D, taking into consideration the
regional differences across various cultures, and focuses on
comorbidities and interventions at all levels. Efforts for an
Asian Indian customization that will reflect various physio-
logic, nutritional, epidemiologic, pathologic, and anthropo-
metric factors, as well as nutritional and cultural factors, are
in progress and will be incorporated into the algorithm tem-
plate. The goal of this initiative is to provide guidance to
physicians in the management of prediabetes and T2D in a
much more structured, systematic, and effective way.
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